No abstract available
Keywords:
IgM neuropathy; anti-MAG neuropathy; lenalidomide; outcome measures; rituximab.
MeSH terms
-
Aged
-
Female
-
Humans
-
Immunoglobulin M / drug effects
-
Lenalidomide
-
Myelin-Associated Glycoprotein / antagonists & inhibitors*
-
Myelin-Associated Glycoprotein / metabolism
-
Peripheral Nervous System Diseases / diagnosis
-
Peripheral Nervous System Diseases / drug therapy*
-
Rituximab / therapeutic use
-
Thalidomide / analogs & derivatives*
-
Thalidomide / therapeutic use
-
Treatment Outcome
Substances
-
Immunoglobulin M
-
Myelin-Associated Glycoprotein
-
Rituximab
-
Thalidomide
-
Lenalidomide